Cancer

In a study led by Stanford Medicine, researchers harnessed the skin’s immune response to bacteria to create an immunotherapy — delivered by swab — that treats aggressive tumors in mice.

Tiny circles of DNA harbor cancer-associated oncogenes and immunomodulatory genes promoting cancer development. They arise during transformation from pre-cancer to cancer, say Stanford Medicine-led team.

A novel Stanford School of Medicine partnership uncovers a direct link between a cancer-associated gene, Myc, and sugar patterns on cancer cell surfaces that tell immune cells to stand down.

Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.

Neutrophils often suppress the immune system’s response to cancer, but when activated, they eliminate several types of tumors in laboratory mice, a study led by Stanford Medicine has found.

The collaboration will enable the development of medications to treat a type of brain cancer.

Shoshana Levy discovered a family of molecules called tetraspanins, launching a new field of cancer research. She was an active researcher, collaborator and mentor at Stanford Medicine for nearly three decades.

After finding long, repetitive sequences in the genomes of seven kinds of cancer, researchers at Stanford Medicine and their colleagues developed a molecule that curbed their production.

Antiviral medicine eliminates hepatitis C in 97% of patients, but Stanford Medicine researchers and colleagues find that many don’t receive the treatment.

Grace Lee, Crystal Mackall, Paul Mischel, Kari Nadeau, Anthony Oro and Krishna Shenoy are among the 100 members elected this year to the National Academy of Medicine.

A new PhD program, hosted by the departments of radiology and radiation oncology, trains students in technologies used for therapy and diagnostics.